Francisco Bautista Selected Research

Francisco Bautista Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 08/2014
4	Leukemia 04/2024 - 11/2016
4	Glioma (Gliomas) 01/2020 - 08/2010
3	Philadelphia Chromosome 12/2023 - 12/2019
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 12/2019
3	Neuroblastoma 01/2022 - 01/2017
3	Fever (Fevers) 11/2021 - 10/2019
2	Lymphoma (Lymphomas) 04/2024 - 12/2023
2	COVID-19 02/2024 - 12/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 12/2022
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2021
2	Pain (Aches) 11/2021 - 09/2006
2	Disease Progression 01/2021 - 01/2020
1	Neutropenia 12/2023
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Rhabdomyosarcoma 11/2023
1	Central Nervous System Neoplasms 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Multiple Myeloma 12/2022
1	Capillary Leak Syndrome 11/2021
1	Hypersensitivity (Allergy) 11/2021
1	Headache (Headaches) 01/2021
1	Residual Neoplasm 01/2020
1	Obesity 01/2020
1	Human Influenza (Influenza) 10/2019
1	Ependymoma 01/2016
1	Peritoneal Neoplasms 08/2014
1	Ganglioglioma 06/2014
1	Hyperbilirubinemia 01/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012
1	Neurogenic Inflammation 09/2006
1	Hyperalgesia 09/2006
1	Inflammation (Inflammations) 09/2006

Drug/Important Bio-Agent (IBA)

4	nilotinib FDA Link 12/2023 - 12/2019
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2019
3	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 12/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2019
2	Dasatinib (BMS 354825)FDA Link 12/2023 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 01/2017
2	Topotecan (Hycamtin)FDA LinkGeneric 11/2021 - 01/2017
2	Ifosfamide FDA LinkGeneric 11/2021 - 01/2021
2	AntibodiesIBA 11/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 01/2021
2	lenvatinibIBA 11/2021 - 01/2021
1	Heavy MetalsIBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	adavosertibIBA 12/2023
1	Carboplatin (JM8)FDA LinkGeneric 12/2023
1	regorafenibIBA 11/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2023
1	talimogene laherparepvecIBA 01/2023
1	Proteasome InhibitorsIBA 12/2022
1	carfilzomibIBA 12/2022
1	ribociclibIBA 11/2021
1	Everolimus FDA Link 11/2021
1	dinutuximabIBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	TransferasesIBA 01/2021
1	BilirubinIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Nicotine FDA Link 01/2020
1	CotinineIBA 01/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020
1	blinatumomabIBA 01/2020
1	Oseltamivir (Tamiflu)FDA Link 10/2019
1	dipinacoline glutamateIBA 03/2019
1	Antineoplastic Agents (Antineoplastics)IBA 11/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	VemurafenibIBA 06/2014
1	Alanine Transaminase (SGPT)IBA 01/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012
1	Clofarabine (Clolar)FDA Link 01/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2012
1	Capsaicin (Zostrix)FDA Link 09/2006
1	Peptide Hydrolases (Proteases)FDA Link 09/2006
1	PAR-2 ReceptorIBA 09/2006
1	TRPV Cation ChannelsIBA 09/2006
1	Protons (Proton)IBA 09/2006

Therapy/Procedure

9	Therapeutics 05/2024 - 11/2016
8	Investigational Therapies (Experimental Therapy) 05/2024 - 09/2017
4	Immunotherapy 01/2023 - 06/2014
4	Drug Therapy (Chemotherapy) 11/2021 - 08/2010
2	Stem Cell Transplantation 01/2023 - 01/2020
2	Radiotherapy 11/2021 - 03/2019
1	Off-Label Use 04/2024
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Induction Chemotherapy 12/2022
1	Immunomodulation 01/2020
1	Injections 01/2020
1	Re-Irradiation 01/2016
1	Cytoreduction Surgical Procedures 08/2014
1	Hyperthermic Intraperitoneal Chemotherapy 08/2014